Twist Bioscience Corporation (TWST) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Twist Bioscience Corporation (TWST:NASDAQ), powered by AI.

Current Price
$84.95
P/E Ratio
-65.4
Market Cap
5.1B
Sector
Healthcare
What is the Twist Bioscience Corporation stock price forecast?

Twist Bioscience Corporation is currently trading at $84.95. View real-time AI analysis on Alpha Lenz.

What is Twist Bioscience Corporation insider trading activity?

View the latest insider trading data for Twist Bioscience Corporation on Alpha Lenz.

What is Twist Bioscience Corporation's P/E ratio?

Twist Bioscience Corporation's P/E ratio is -65.4.

Twist Bioscience Corporation

NASDAQ · TWST
$84.95+4.16(+5.15%)Pre-marketNASDAQ regular session 09:30–16:00 ET
Ask about Twist Bioscience Corporation's future dividend policy...
Alpha Chat Insight

Twist Bioscience Corporation trades at a P/E of -65.4 (undervalued) with modest ROE of -16.4%. 3Y revenue CAGR of 22.8% highlights clear growth momentum.

Ask for details

Company Overview

Twist Bioscience Corporation is a pioneering biotechnology firm revolutionizing the field of synthetic DNA. The company's primary function is to produce synthetic DNA using a proprietary silicon-based manufacturing platform, enabling the creation of high-quality, accurate, and cost-effective DNA at scale. Twist Bioscience's innovations impact multiple sectors, including pharmaceuticals, industrial chemicals, agriculture, and data storage, offering transformative solutions in drug development, crop protection, and genomic research. By leveraging its proprietary DNA synthesis platform, Twist Bioscience plays a vital role in the broader biotechnology market, facilitating advancements that drive progress in personalized medicine and sustainable practices. With its cutting-edge technology, the company provides researchers and businesses with access to a wide array of DNA products and solutions essential for scientific discovery and technological innovation, underpinning its significance in the expanding biotech landscape.

CEODr. Emily Marine Leproust Ph.D.
SectorHealthcare
IndustryDiagnostics & Research
Employees923

Company Statistics

FY 2025

Profile

$5.08BMarket Cap
$376.57MRevenue
0.00Shares Out
923Employees

Margins

50.72%Gross
-42.56%EBITDA
-36.18%Operating
-20.43%Pre-Tax
-20.63%Net

Valuation

-65.41P/E
10.74P/B
13.49EV/Sales
-31.03EV/EBITDA
-67.18P/FCF

Growth (CAGR)

22.76%Rev 3Yr
33.11%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-12.37%ROA
-16.43%ROE
-21.69%ROIC

Financial Health

$183.05MCash & Cash Equivalents
$-14.15MNet Debt
35.71%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Twist Bioscience Corporation (ticker: TWST) is a company listed on NASDAQ in the Healthcare sector (Diagnostics & Research). It has approximately 923 employees. Market cap is $5.1B.

The current price is $84.95 with a P/E ratio of -65.41x and P/B of 10.74x.

ROE is -16.43% and operating margin is -36.18%. Annual revenue is $377M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Twist Bioscience Corporation (TWST) Stock Forecast 2026 $84.95 — Price, Financials & Analyst Targets | Alpha Lenz